Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine May, 2009 | Pubmed ID: 19372467